NCT01168076
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +9 more
- Locations
-
- InLight Solutions Albuquerque, New Mexico, United States
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
7,968 public trials
717 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT00462436
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Behavior, +17 more
- Locations
-
- St. Michael's Hospital Toronto, Ontario, Canada
NCT00566358
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
- Locations
-
- LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/Univeristy of Campinas (UNICAMP) Campinas, São Paulo, Brazil
NCT00393705
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Zagreb, Croatia
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bialystok, Poland
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rzeszów, Poland
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bucharest, Romania
NCT01159353
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Sanofi-Aventis Administrative Office Paris, France
NCT00654745
- Conditions
- Cardiovascular Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 2, +7 more
- Locations
-
- Los Angeles, California, United States
- Sylmar, California, United States
- Tustin, California, United States
- Aventura, Florida, United States
NCT00812578
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +7 more
- Locations
-
- Medical Research Unit, Medical Department M, Aarhus University Hospital Aarhus, Denmark
NCT01082120
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Research Site Chula Vista, California, United States
Completed
Efficacy of Pioglitazone on Myocardial Function in Patients Undergoing Coronary Stent Implantation.
NCT00771004
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +13 more
- Locations
-
- Hamburg, Free and Hanseatic City of Hamburg, Germany
- Frankfurt am Main, Hesse, Germany
- Kassel, Hesse, Germany
- Wiesbaden, Hesse, Germany
NCT00772174
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Lipoatrophic, Diabetes Mellitus, Type 2, +6 more
- Locations
-
Not specified